Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study: Results from the 6-month continuation phase

OBJECTIVE: To examine the effects of crossing over from optimized multiple daily injection (MDI) therapy to sensor-augmented pump (SAP) therapy for 6 months, and the effects of 18 months’ sustained use of SAP. RESEARCH DESIGN AND METHODS: The 6-month, single-crossover continuation phase of Sensor-Au...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergenstal, Richard M., Tamborlane, William V., Ahmann, Andrew, Buse, John B., Dailey, George, Davis, Stephen N., Joyce, Carol, Perkins, Bruce A., Welsh, John B., Willi, Steven M., Wood, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198292/
https://www.ncbi.nlm.nih.gov/pubmed/21933908
http://dx.doi.org/10.2337/dc11-1248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198292/
https://www.ncbi.nlm.nih.gov/pubmed/21933908
http://dx.doi.org/10.2337/dc11-1248

Ejemplares similares